Reply: To PMID 25234529.
作者信息
Ruggiero Salvatore L
机构信息
Lake Success, NY.
出版信息
J Oral Maxillofac Surg. 2015 Jul;73(7):1239-40. doi: 10.1016/j.joms.2015.03.060. Epub 2015 Apr 24.
PMID:25913511
Abstract
摘要
相似文献
1
Reply: To PMID 25234529.
J Oral Maxillofac Surg. 2015 Jul;73(7):1239-40. doi: 10.1016/j.joms.2015.03.060. Epub 2015 Apr 24.
2
In reply.
J Oral Maxillofac Surg. 2014 Dec;72(12):2381-2. doi: 10.1016/j.joms.2014.08.017. Epub 2014 Oct 7.
3
Incongruities in the AAOMS position paper: medication-related osteonecrosis of the jaw--2014 update.
J Oral Maxillofac Surg. 2014 Dec;72(12):2381. doi: 10.1016/j.joms.2014.07.045. Epub 2014 Oct 12.
4
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update and CTX.
J Oral Maxillofac Surg. 2015 Mar;73(3):377. doi: 10.1016/j.joms.2014.10.035.
5
C-Terminal Telopeptide—Science or Politics?
J Oral Maxillofac Surg. 2015 Jul;73(7):1239. doi: 10.1016/j.joms.2015.03.058. Epub 2015 Apr 27.
6
Aflibercept: osteonecrosis of the jaw: Watch out for high-risk situations.
Prescrire Int. 2016 Nov;25(176):271.
7
Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):479-87. doi: 10.1016/j.coms.2015.06.008. Epub 2015 Aug 18.
8
[Osteonecrosis of the jaw].
Endokrynol Pol. 2011;62 Suppl 3:4-9.
9
[Focus: Drug-related osteonecrosis of the jaw].
Presse Med. 2018 Jan;47(1):19-33. doi: 10.1016/j.lpm.2017.10.009. Epub 2017 Dec 21.
10
Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
Oncologist. 2008 Dec;13(12):1314; author reply 1315. doi: 10.1634/theoncologist.2008-0206. Epub 2008 Dec 16.
Zotero 插件